Introduction
Many different extracellular signals activate protein-tyrosine kinases [1] [2] [3] , which in turn initiate cascades of protein-protein interactions that lead to changes in gene expression, cytoskeletal architecture and cell metabolism. These protein-protein interactions are mediated by Srchomology 2 (SH2) and phosphotyrosine-binding (PTB) domains, which bind to specific tyrosine phosphorylation sites [4] [5] [6] .
The adaptor protein Shc contains an amino-terminal PTB domain, a central proline-rich region (CH1), and a carboxyterminal SH2 domain [7] . The Shc PTB domain was recognized recently as a protein module of approximately 160 amino-acid residues that binds to phosphotyrosine (pY) in the context of specific amino-terminal residues, recognizing the sequence XNPXpY (single-letter amino-acid code; indicates a large non-polar residue and X any amino acid) [8] [9] [10] [11] . Shc PTB-binding sites have been identified in a number of growth factor receptors [4, 5] , and two potential Shc PTB-binding sites are present in the SHIP inositol phosphatase [12] [13] [14] . The CH1 region of Shc apparently provides a scaffold for further protein interactions: the tyrosine at position 317 (Y317) is contained within a binding site for the SH2 domain of Grb2, and some stretches that are rich in proline residues may constitute binding sites for Src-homology 3 (SH3) domains [7, 15, 16] . The SH2 domain at the carboxyl terminus of Shc binds, in vitro, to phosphorylated tyrosine residues in the context of a large non-polar amino acid at the +3 position [17] , but physiological Shc SH2 domain-binding sites have not been identified with certainty.
The Shc gene encodes three widely expressed proteins, p46 Shc , p52 Shc and p66 Shc , which differ only in the extent of their amino-terminal sequences [7] . Two mammalian Shc-related polypeptides, ShcB (also known as Sck) and ShcC, have been identified recently, and have been shown to be expressed predominantly in the brain [9, 18] . The sequence conservation between different mammalian Shc family members is highest within their PTB and SH2 domains [9, 18] ; the central CH1 region contains only three short stretches of conserved amino acids, of which two centre around tyrosine residues. One such conserved motif (YYNS/DPXKXPP) contains Y239 and Y240 of Shc, the second motif (YVNXQ) includes the Shc Y317 phosphorylation site [7, 15] , and the third conserved motif, which associates with adaptins, is predicted to form a turn [19] . A Shc protein has also been identified recently in Drosophila [20] . It is of interest to note that the CH1 residues homologous to Shc Y239 and Y240 are present in Drosophila Shc, whereas the Shc Y317-containing motif is absent.
Shc polypeptides become phosphorylated on tyrosine and serine residues in response to a wide variety of stimuli [4, 21] . Tyrosine-phosphorylated Shc can associate with Grb2 [15, 16, 22] , and through its association with the Grb2/Sos complex may be linked to activation of the Ras/MAP kinase pathway [23] [24] [25] [26] [27] . Our understanding of Shc phosphorylation is limited to the characterization of the Y317 phosphorylation site [15] . Y317 is present within a consensus binding site for the Grb2 SH2 domain (pYXNX) [17] , and it is generally accepted that Grb2 associates with Shc through Y317. Here, we have analyzed tyrosine phosphorylation of Shc in detail and have identified Y239 and Y240 as two novel and major tyrosine phosphorylation sites. Our data indicate that these two phosphotyrosine sites contribute significantly to the interaction of Shc with Grb2 following growth factor stimulation. Furthermore, Y239 and Y240 may be involved in binding several tyrosine-phosphorylated proteins.
Results

Shc is co-ordinately phosphorylated at Y239 and Y240 by v-Src in vitro
Shc becomes phosphorylated on tyrosine and serine residues in response to numerous stimuli, suggesting that its phosphorylation is of general importance for signal transduction. Phosphoamino-acid analysis performed in the initial study to characterize Shc phosphorylation in response to epidermal growth factor (EGF) showed a spot with a mobility different from phosphoserine, phosphothreonine or phosphotyrosine [7] . To confirm this initial observation, NIH3T3 cells overexpressing the EGF receptor were labeled with 32 P-orthophosphate and stimulated with EGF; a similar 32 P-labeling was undertaken with vsrc-transformed Rat-2 cells. Shc was isolated from these cells and subjected to partial acid hydrolysis. Separation of the hydrolysis products by electrophoresis in two dimensions on thin-layer cellulose (TLC) plates showed the presence of an additional radiolabeled spot that did not correspond to any of the phosphorylated hydroxy-amino acids (Fig. 1) . The migration of this novel product suggested that it may represent a dimer of two phosphorylated amino acids. This hydrolysis product was recovered from the TLC plate and subjected to further acid hydrolysis and a subsequent round of phosphoamino-acid analysis. Acid hydrolysis generated phosphotyrosine in addition to the original compound (Fig. 1c) , but not phosphoserine or phosphothreonine, consistent with the possibility that this hydrolysis product is composed of two phosphotyrosine residues.
Shc contains only one site with two neighbouring tyrosine residues, at positions 239 and 240. Co-incident phosphorylation of these adjacent tyrosines within the same molecule could generate a di-phosphopeptide. To test this possibility, two glutathione S-transferase (GST)-fusion proteins containing Shc residues 1-225 (GST-Shc 1-225 ) or 1-307 (GST-Shc 1-307 ) were phosphorylated in vitro using purified v-Src kinase. As a potential substrate for proteintyrosine kinases, GST-Shc 1-307 differs from GST-Shc 1436 Current Biology 1996, Vol 6 No 11
Figure 1
Acid hydrolysis of Shc isolated from in vivo 32 P-labeled cells reveals a product that does not comigrate with phosphoserine (P.Ser), phosphothreonine (P.Thr), or phosphotyrosine (P.Tyr). Shc polypeptides isolated from 32 P-orthophosphate-labeled EGFstimulated HER14 or v-src-transformed fibroblasts were transferred to PVDF membranes and hydrolyzed in hydrochloric acid. The hydrolysis products were separated in the presence of P.Ser, P.Thr, and P.Tyr markers by electrophoresis at pH 1.9 and pH 3. by the presence of only two additional tyrosine residues, Y239 and Y240 (Fig. 2a) . A fusion protein that contains Shc Y317, but not Y239/240 (GST-Shc 280-473 ), was used as a control. GST-Shc 1-307 was a better substrate for the Src protein-tyrosine kinase than GST-Shc 1-225 , suggesting that Y239 and Y240 may be good sites for phosphorylation by v-Src (Fig. 2b,c) . To test this possibility directly, Y239 and Y240 were mutated to phenylalanine, individually and in combination, in the GST-Shc 1-307 fusion protein. Substitution of both Y239 and Y240 with phenylalanine significantly reduced the extent of phosphorylation of the GST-Shc 1-307 fusion protein by v-Src (Fig. 2b,c) .
The GST-Shc 1-225 and the GST-Shc 1-307 fusion proteins were phosphorylated with v-Src, resolved by SDS-PAGE and isolated from the dried gel after autoradiography, and were hydrolyzed for phosphoamino-acid analysis or digested with trypsin for phosphopeptide mapping. Phosphoamino-acid analysis showed that phosphorylated GST-Shc 1-307 had the novel extra spot whereas phosphorylated GST-Shc 1-225 did not (Fig. 3) . The intensity of the extra spot was low following phosphorylation by Src in vitro -this may be caused by low stoichiometry of phosphorylation in vitro, or may indicate that the singly phosphorylated site is a poor substrate for Src. Substitution of either Y239 or Y240 with phenylalanine resulted in disappearance of the extra spot in the phosphoamino-acid analysis (Fig. 3) , further suggesting that the novel spot represents a dipeptide containing phosphorylated tyrosine residues 239 and 240.
Research Paper Identification of novel Shc phosphorylation sites van der Geer et al. 1437 Phosphopeptide mapping of the two GST fusion proteins phosphorylated in vitro by v-Src showed that GST-Shc 1-307 contained a phosphopeptide that was missing in phosphorylated GST-Shc 1-225 ( Fig. 4a,b ). This phosphopeptide migrated in the same position as a major phosphopeptide present in tryptic digests of in vivo 32 P-labeled p46 Shc isolated from v-src transformed cells (Fig. 4d) . Substitution of both Y239 and Y240 with phenylalanine resulted in disappearance of the phosphopeptide unique to GST-Shc 1-307 (Fig. 4c ). These data add support to the idea that Y239 and 240 are phosphorylated by v-Src in vitro, and suggest that these sites are also phosphorylated in vivo.
Y239 and Y240 are highly phosphorylated by v-Src and the activated EGF receptor in vivo
To study Shc phosphorylation in vivo, the mutations affecting Y239 and Y240 were introduced into a cDNA encoding the full-length 52 kDa isoform of Shc with an haemagglutinin (HA) epitope at the amino terminus.
Wild-type, F239, F240 and F239/240 (2F) mutant proteins were then expressed by transient transfection in COS1 cells. To compare the phosphorylation of the wild-type and mutant Shc proteins, the COS1 cells were co-transfected with a v-src expression vector. Analysis of anti-HA immunoprecipitates by immunoblotting with an anti-Shc polyclonal antiserum, showed that wild-type and mutant Shc proteins were expressed at very similar levels in transfected cells (Fig. 5a ). Immunoblotting of parallel HAimmunoprecipitates with a polyclonal anti-phosphotyrosine antiserum showed that wild-type protein was highly tyrosine-phosphorylated in these v-Src-expressing COS1 cells (Fig. 5b) . However, the 2F mutant Shc contained considerably lower levels of phosphotyrosine, and the single mutants F239 and F240 showed intermediate levels of tyrosine phosphorylation. These data indicate that both Y239 and Y240 are phosphorylated in cells expressing the v-Src cytoplasmic protein-tyrosine kinase.
To study phosphorylation of these Shc proteins in response to activation of a receptor protein-tyrosine kinase, COS1 cells were transiently transfected with the Shc expression constructs, starved for 24 hours in serumfree medium and stimulated with EGF for 5 minutes at 37°C. Wild-type and mutant Shc proteins were expressed 1438 Current Biology 1996, Vol 6 No 11
Figure 4
GST-Shc 1-307 phosphorylated in vitro by Src and p46 Shc isolated from Src-transformed cells have a tryptic phosphopeptide in common. GST-Shc fusion proteins phosphorylated in vitro by purified Src (see Fig. 2b ), and p46 Shc isolated by immunoprecipitation from 32 P-labeled v-src-transformed fibroblasts, were isolated from the gel and digested with trypsin. The digestion products were separated in two dimensions by electrophoresis at pH 1.9 and chromatography in phosphochromatography buffer on TLC plates. Phosphopeptides were visualized by autoradiography in the presence of an intensifier screen. at very similar levels (Fig. 6a) . Anti-phosphotyrosine blotting of anti-HA immunoprecipitates showed strong tyrosine phosphorylation of the wild-type Shc protein in response to EGF. In contrast, the 2F mutant was more weakly tyrosine phosphorylated and the single F239 and F240 mutants were phosphorylated to intermediate levels, as also observed in the v-Src-expressing cells. Wild-type and mutant proteins showed equivalent association with the activated EGF receptor (Fig. 6b) . Phosphoamino-acid analysis of HA-tagged Shc proteins (labeled with 32 P in vivo) isolated from EGF-stimulated COS1 cells showed that mutant proteins with both Y239 and Y240 substituted with phenylalanine lacked the extra spot characteristic of wild-type Shc. These data indicate that Y239 and Y240 are major in vivo sites of phosphorylation in response to growth factor stimulation. Furthermore, the prominent representation of the di-phosphopeptide in acid hydrolysates of Shc phosphorylated in vivo suggests that both tyrosines are commonly phosphorylated in the same molecule.
The relative extent to which Shc was phosphorylated at either Y239/240 or Y317 was directly compared by transiently expressing HA-tagged wild-type or mutant proteins in COS1 cells. Substitution of Y317 with phenylalanine resulted in a decrease in EGF-induced Shc tyrosine phosphorylation. However, substitution of Y239/240 caused a more marked reduction in the EGF-induced tyrosine phosphorylation of Shc than did substitution of Y317 (Fig.  7b) . These data indicate that Y239/240, as well as Y317, are important Shc phosphorylation sites.
Phosphorylation of Shc Y239/240 induces binding of cellular proteins
A likely function of the Y239/240 phosphorylation sites is to provide binding sites for modules that recognize phosphotyrosine, such as SH2 or PTB domains. Examination of the amino-acid sequence around these sites showed that Y239 is present within a consensus binding sequence for the Grb2 SH2 domain, pYXNX [17] , and might therefore interact with Grb2. To test this possibility, 12-amino acid peptides based on the sequence around Y239 and Y240 (residues 236-247) were tested for their ability to bind to Grb2. The unphosphorylated peptide (YY), peptides phosphorylated on either Y239 or Y240 (pY-Y and Y-pY, respectively), and the doubly phosphorylated peptide (pY-pY) were biotinylated, immobilized on Streptavidin-agarose and incubated with cell lysates from v-Src-expressing fibroblasts. Bound proteins were analyzed by anti-Grb2 immunoblotting. Peptides phosphorylated on Y239 and peptides phosphorylated on both Y239 and Y240 bound to Grb2 present in these cell lysates (Fig. 8a) , whereas unphosphorylated peptides or peptides phosphorylated on Y240 did not.
To extend this analysis to full-length Shc, lysates from control and EGF-stimulated COS1 cells expressing wildtype and mutant HA-tagged Shc proteins were incubated with immobilized GST-Grb2 SH2 domain fusion proteins. In this experiment, wild-type HA-tagged Shc from EGFstimulated cells bound strongly to the Grb2 SH2 domain in vitro, whereas the single or double mutant proteins with substitutions at Y239/240 bound significantly less well (Fig.  8b) . To test for association of Grb2 with HA-tagged Shc in vivo, HA immunoprecipitates from transiently transfected control and EGF-stimulated COS1 cells were analyzed by anti-Grb2 immunoblotting. Grb2 was easily detected in HA immunoprecipitates from EGF-stimulated COS1 cells expressing the wild-type HA-tagged Shc protein. The F239 and F240 single, and the 2F double mutant proteins coprecipitated significantly less Grb2, consistent with a model in which the twin tyrosine residues constitute a major Grb2 binding site in Shc (Fig. 8c) .
The relative involvement of Y239/240 and Y317 in Grb2-binding were then compared directly. Whereas mutation of Y317 moderately reduced binding of HA-tagged Shc to Grb2 following EGF stimulation, the substitution of Y239/240 with phenylalanines resulted in a large decrease in Grb2 binding (Fig. 7c) . These data suggest that, while the Y239/240 and Y317 sites both interact with Grb2, To test whether these phosphorylation sites could be involved in interactions with proteins other than Grb2, we used the phosphotyrosine-containing peptides based on the sequence around Y239 and Y240 as affinity reagents. Immobilized peptides were incubated with cell lysates of v-Src expressing cells and bound proteins were eluted and analyzed by anti-phosphotyrosine blotting. Unphosphorylated peptides or peptides phosphorylated on Y240 did not specifically bind any phosphotyrosine-containing proteins. Peptides phosphorylated on Y239 or phosphorylated on both Y239 and Y240 bound to a number of tyrosine phosphorylated proteins. We reproducibly observed binding of proteins with molecular weights of ~22, ~40 and 160 kDa. Interestingly, the peptide phosphorylated singly on Y239 appeared to bind to p40 with greater affinity than the doubly phosphorylated peptide; in contrast, the doubly phosphorylated peptide appeared to bind with greater affinity to p22 and p160 (Fig. 9) . These data suggest that Shc may change binding partners depending on the phosphorylation status of Y239 and Y240.
Discussion
A wealth of data suggest that the phosphorylation of Shc is an important step in signal transduction initiated by a wide variety of extracellular stimuli. Y317, located in the carboxyterminal half of the central CH1 region of Shc, has been identified previously as an important site of phosphorylation [7, 15] . Here, we have analyzed Shc phosphorylation and have identified Y239 and Y240 as two additional phosphorylation sites. A combination of phosphopeptide mapping, phosphoamino-acid analysis, and site-directed mutagenesis have shown that Y239 and Y240 are principal sites of Shc phosphorylation by v-Src in vitro, and by v-Src and the activated EGF receptor in vivo. Identification of a di-phosphopeptide containing phosphorylated Y239/240 indicates that both sites are efficiently phosphorylated within individual Shc molecules, for example in EGF-stimulated cells. The remaining tyrosine phosphorylation observed when Y239 and Y240 are both changed to phenylalanine can be accounted for by phosphorylation at Y317. Consistent with our results, previous work indicated that a full-length mutant Shc protein with phenylalanine at residue 317 could still be phosphorylated on tyrosine in vivo [15] .
We have compared the sequence around Y239/240 of Shc with the corresponding sequences in the ShcB and ShcC polypeptides [9, 18] . Both tyrosine residues and the surrounding amino-acid sequences are conserved between the three mammalian Shc family members (Fig. 1) . The sequence relationship amino-terminal to the twin tyrosine residues is limited to the presence of acidic amino-acid residues that may be involved in recognition by proteintyrosine kinases. Sequence conservation is quite extensive within the 18 residues carboxy-terminal to the adjacent tyrosines, suggesting that the function of Y239 and Y240 is conserved between the Shc family members. It is intriguing that the sequence conservation extends considerably beyond the 3-5 residues needed to provide a binding surface for an SH2 domain [17, 28] , suggesting that multiple functions may be performed by this island of conserved amino-acid residues. Two adjacent tyrosine residues are also present in Drosophila Shc, and are found within a YYNDXPXKXPP motif which is conserved between the human and the Drosophila polypeptides. This is in contrast to Y317, which is not found in Drosophila Shc [20] -suggesting that the function of Y239 and 240 has been established early in evolution and may be conserved between Drosophila and man, whereas the function of Y317 may have evolved more recently.
Y239 is present within the context of a Grb2 SH2 domain consensus binding site, pYXNX [17] . Peptide-binding Peptides kDa studies show that both the Y239 mono-phosphorylated and the di-phosphorylated peptides can bind to Grb2 present in cell lysates. The unphosphorylated peptide or the peptide phosphorylated on Y240 did not bind to Grb2. In vivo, wild-type HA-tagged Shc bound strongly to Grb2, but mutant Shc proteins in which Y239 and Y240 had been changed, either individually or together, to phenylalanine demonstrated a strongly reduced ability to associate with Grb2, suggesting that Y239 constitutes a major Grb2 binding site. It not clear why the F240 mutant binds Grb2 with greatly reduced affinity compared with the wild-type protein in vivo. It is possible that the phenylalanine at the 240 position interferes with Grb2 recognition. Alternatively, Y239 may be phosphorylated less efficiently when it is followed by phenylalanine, perhaps because the protein-tyrosine kinase that phosphorylates Y239 preferentially recognizes this site in the context of a phosphotyrosine at position 240. A third possibility is that the double-phosphorylated site has a higher affinity for the Grb2 SH2 domain. With this in mind, it is of interest to note that adjacent tyrosine residues followed by an asparagine are present in the Drosophila and Caenorhabditis elegans homologs of the EGF receptor, DER and Let23 [29, 30] . Both receptor protein-tyrosine kinases have been shown genetically to interact with Grb2 [31] [32] [33] [34] . A YYN motif is also present in the recently described Daughterof-Sevenless (Dos) protein, which contains a pleckstrin homology domain [35] ; both Dos and Drk, the Drosophila homolog of Grb2, are required for efficient signalling downstream of Sevenless.
The presence of two tyrosine residues within one SH2 binding site raises the possibility of signal integration. It is possible that complete phosphorylation of these two sites depends on the activation of two different protein-tyrosine kinases; activation of the first kinase would result in phosphorylation of one of the two tyrosine residues, creating a phosphorylation site for the second kinase. Thus, complete phosphorylation of this site may result from activation of two signalling pathways. In this context, it is of interest that, in vitro, peptides phosphorylated on Y239 appear to bind a tyrosine-phosphorylated protein that is not bound by the doubly phosphorylated peptide. Conversely, the doubly phosphorylated peptide appears to bind to tyrosine phosphorylated proteins that are not bound by peptides phosphorylated on Y239 alone, whereas both peptides bind Grb2. This suggests that different signalling pathways might be activated downstream of Shc depending on the phosphorylation of Shc at the Y239 and Y240 sites (Fig.  10) . We are currently investigating the proteins that interact with phosphorylated Y239 and Y240. Their identification may provide further insights in the role of Shc during signal transduction.
Conclusions
Shc polypeptides are general substrates for protein-tyrosine kinases that become activated in response to a variety of extracellular stimuli. Analysis of Shc tyrosinephosphorylation has been limited to the characterization of Y317. Here, we have identified two novel tyrosine phosphorylation sites, Y239 and Y240. These twin tyrosine residues are phosphorylated in vitro by purified Src kinase, and in vivo in v-src-transformed and EGF-stimulated cells. These novel sites are highly phosphorylated in vivo, and both tyrosine residues are frequently phosphorylated in the same polypeptide. The Y239/240 Shc sites are highly conserved in evolution, suggesting that they are of physiological importance.
Y239 is present within a consensus-binding site for the Grb2 SH2 domain, and phosphorylation of Shc at both tyrosine residues is important for its association with Grb2 in vivo. This raises the possibility that the Grb2 SH2 domain may recognize sites that contain two phosphorylated tyrosine residues. Phosphopeptides based on the sequence around Y239/240 bind Grb2 and several tyrosine-phosphorylated proteins in lysates of v-src-transformed cell. These data suggest that these phosphorylation sites may function as binding sites for one or more signalling proteins. Their identification may lead to further understanding of Shc's role in normal and malignant signal transduction.
Materials and methods
Cells lines and antibodies
HER14 human EGF receptor overexpressing NIH3T3 cells [36] were grown in Dulbecco-Vogt modified Eagles medium (DMEM) containing 10 % fetal bovine serum (FBS) and 400 g ml -1 G418; S7A v-srctransformed Rat-2 cells [37] were grown in DMEM containing 10 % FBS; v-src-transformed embryonic fibroblasts were grown in DMEM Figure 10 Shc contains three tyrosine phosphorylation sites in the proline-rich CH1 region -Y239 and Y240 identified here, and Y317 identified previously [15] . Both the tandem phosphorylation sites and Y317 contribute to Grb2 binding. Y239/240 appear to be involved in the interaction with a number of additional phosphotyrosine-containing proteins in v-src-transformed cells.
containing 5 % calf serum (CS); and COS1 cells [38] were grown in DMEM containing 10 % CS. Polyclonal anti-Shc [7] and anti-pY [39] sera were raised as described. Polyclonal anti-Grb2 serum C-23, monoclonal anti-pY 4G10, and monoclonal anti-HA 12CA5 were purchased from Santa Cruz Biotechnology (Santa Cruz, California), UBI (Lake Placid, New York), and Babco (Richmond, California), respectively.
GST fusion proteins
GST-Shc 1-225 and GST-Shc 1-307 are identical to GST-ShcB and GST-ShcC [8] . GST-Shc 280-473 is identical to GST-Shc + and contains p52Shc residues 280-473 [15] . The GST-Grb2 SH2 fusion protein has been described before [16] . Mutants were generated using a PCR-based strategy; mutant cDNA fragments were sequenced to ensure fidelity and cloned back into the pGEX constructs. Fusion proteins were induced and purified as described before [8] .
Expression of wild-type and mutant HA-tagged Shc polypeptides in mammalian cells
Wild-type and mutant human Shc cDNAs were cloned into the mammalian expression vector pcDNA3, a Kozak consensus sequence for initiation of protein synthesis and a sequence encoding the HA epitope starting with a methionine, were linked in frame by a sequence encoding 13 amino acids to the Shc cDNA starting at the first residue of the 52 kDa isoform. COS1 cells at 50 % confluency were transfected with 5 g pcDNA3 HA-Shc with or without 1 g v-src cloned into pECE; transfections were carried out using Lipofectin and Optimem (Gibco-BRL, Burlington, Ontario L7P 1A1) according to manufacturers directions. Cells were lysed 72 h after transfection.
Immunoprecipitation, peptide-affinity purification and immunoblotting
Cells were grown to subconfluence on 10 cm tissue culture dishes. If cells were to be stimulated with EGF, they were starved for 14-16 h in DMEM containing 0.5 % FBS and 20 mM Hepes (pH 7.2). Control cells or cells stimulated with 100 ng ml -1 EGF for 5 min at 37°C were lysed in PLC-lysis buffer and immunoprecipitations were carried out exactly as described before [8] . To test for binding of phosphotyrosinecontaining proteins to phosphopeptides, PLC lysates were incubated with biotinylated peptides that had been immobilized on streptavidinSepharose beads. Sepharose beads were collected by centrifugation and washed 4 times with PLC-lysis buffer. Immunoprecipitates were boiled for 3 min in 62.5 M Tris-Cl (pH 6.8), 10 % glycerol, 5 % ␤-mercaptoethanol, 5 mM DTT, 2.3 % SDS, and 0.025 % bromophenol blue (SDS-sample buffer) and resolved by SDS-PAGE. Peptide bound proteins were eluted with 100 mM triethylamine, boiled in SDS-sample buffer, and resolved by SDS-PAGE. Transfer to PVDF membranes and immunoblotting were carried out as described [8] .
Phosphoamino-acid analysis and tryptic phosphopeptide mapping
Cells were grown to confluence on 10 cm plates, starved in serum-free medium if necessary, and labeled for 4 h in 5 ml phosphate-free DMEM containing 0.5 % dialyzed FBS and 1 mCi ml -1 32 P-orthophosphate. v-Src-transformed cells were labeled in medium containing 5 % dialyzed FBS. Cells were rinsed twice with ice cold phosphate-buffered saline (PBS) and lysed in 1 ml PLC lysis buffer per 10 cm tissue culture dish. Shc proteins were isolated by immunoprecipitation with anti-Shc serum or anti-HA antibodies and resolved by SDS-PAGE. GST-fusion proteins were immobilized on glutathione-agarose phosphorylated in vitro by incubation with purified v-Src kinase (Oncogene Science, Cambridge, Massuchusetts) and ␥-[ 32 P]ATP in 25 mM Hepes (pH 7.2), 5 mM MnCl 2 , 5 mM MgCl 2 and 1 mM DTT for 30 min at 30°C. Following phosphorylation, the GST-fusion proteins bound to glutathioneagarose were washed twice with PLC-LB and samples were resolved by SDS-PAGE. For phosphopeptide mapping, proteins were recovered from the dried gel after autoradiography, concentrated by TCA precipitation and digested with trypsin as described [40] . Tryptic digests were resolved by electrophoresis at 1000 V for 30 min at pH 1.9 and chromatography in phosphochromobuffer. Phosphopeptides were visualized by autoradiography. For phosphoamino-acid analysis, proteins were hydrolyzed in 6 M HCl for 60 min at 110°C after transfer to PVDF membrane or after isolation from the dried gel as described [40] . For phosphoamino-acid analysis of transiently expressed HAtagged Shc, proteins were transferred to PVDF membranes; to reduce background, most phosphopeptides were eluted from the membrane during digestion with trypsin before acid hydrolysis. The phosphopeptide that gives rise to the di-phosphopeptide (pY-pY) following acid hydrolysis is not eluted from the membrane during digestion with trypsin.
Phosphopeptides were synthesized as described [41] . A biotin residue was added to the amino-terminal end of each peptide during the synthesis through addition of Fmoc-⑀-aminocaproic acid (Bachem Bioscience, Torrance, California), followed by piperidine deprotection and the direct incorporation of biotin, predissolved in a minimal volume of DMSO, using HBTU activation. Cleavage of the peptide from the resin and deprotection was achieved through a 90 min incubation at room temperature in trifluoroacetic acid (10 ml) and a scavenger mixture composed of water, thioanisole, 1,2-ethanedithiol (5.0:0.2:0.1 % by volume) and solid phenol (75 mg). The product was precipitated with cold t-butyl ethyl ether, collected by centrifugation and purified using reverse phase HPLC. The authenticity of the phosphopeptides were confirmed by amino-acid analysis and mass spectroscopy.
